JPWO2023033130A1 - - Google Patents
Info
- Publication number
- JPWO2023033130A1 JPWO2023033130A1 JP2023508573A JP2023508573A JPWO2023033130A1 JP WO2023033130 A1 JPWO2023033130 A1 JP WO2023033130A1 JP 2023508573 A JP2023508573 A JP 2023508573A JP 2023508573 A JP2023508573 A JP 2023508573A JP WO2023033130 A1 JPWO2023033130 A1 JP WO2023033130A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021144208 | 2021-09-03 | ||
| PCT/JP2022/033056 WO2023033130A1 (ja) | 2021-09-03 | 2022-09-02 | 骨疾患を処置または予防するための組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023033130A1 true JPWO2023033130A1 (https=) | 2023-03-09 |
Family
ID=85412433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023508573A Pending JPWO2023033130A1 (https=) | 2021-09-03 | 2022-09-02 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023033130A1 (https=) |
| WO (1) | WO2023033130A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025254987A1 (en) * | 2024-06-03 | 2025-12-11 | Alector Llc | Siglec-9 ecd fusion molecule variants and methods of use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015166694A (ja) * | 2014-03-03 | 2015-09-24 | 国立大学法人名古屋大学 | 幹細胞の培養産物の評価指標及びその利用 |
| JP2019500014A (ja) * | 2015-10-29 | 2019-01-10 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ−９抗体及びその使用方法 |
| WO2019230859A1 (ja) * | 2018-05-31 | 2019-12-05 | 国立大学法人徳島大学 | 変形性関節症の処置および／または予防方法 |
-
2022
- 2022-09-02 JP JP2023508573A patent/JPWO2023033130A1/ja active Pending
- 2022-09-02 WO PCT/JP2022/033056 patent/WO2023033130A1/ja not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015166694A (ja) * | 2014-03-03 | 2015-09-24 | 国立大学法人名古屋大学 | 幹細胞の培養産物の評価指標及びその利用 |
| JP2019500014A (ja) * | 2015-10-29 | 2019-01-10 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ−９抗体及びその使用方法 |
| WO2019230859A1 (ja) * | 2018-05-31 | 2019-12-05 | 国立大学法人徳島大学 | 変形性関節症の処置および／または予防方法 |
Non-Patent Citations (7)
| Title |
|---|
| ARTHRITIS RESEARCH AND THERAPY, vol. 18, JPN6023013702, 2016, pages 133, ISSN: 0005171104 * |
| BONE, vol. 143, JPN6023013701, 30 September 2020 (2020-09-30), pages 115665, ISSN: 0005171103 * |
| BONE, vol. 83, JPN6023013697, 2016, pages 210 - 219, ISSN: 0005171099 * |
| INTERNATIONAL JOURNAL OF ORAL MAXILLOFACIAL SURGERY, vol. Vol.46, Suppl.1, S345, JPN6023013699, 2017, ISSN: 0005171101 * |
| JOURNAL OF HARD TISSUE BIOLOGY, vol. 28, no. 4, JPN6023013698, 2019, pages 349 - 358, ISSN: 0005171100 * |
| JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, MEDICINE, AND PATHOLOGY, vol. 31, JPN6023013700, 2019, pages 169 - 174, ISSN: 0005171102 * |
| 小児歯科学雑誌, vol. 56, no. 2, JPN6023013696, 2018, pages 227 - 035, ISSN: 0005171098 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023033130A1 (ja) | 2023-03-09 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230207 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20230207 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230220 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20230207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230411 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231010 |